Sildenafil and Pharma: A Precarious Bet?

The history of Sildenafil presents a intricate picture for those considering investment. click here While the initial release generated substantial returns, the expiration of its intellectual property protection opened the floodgates to off-brand alternatives, dramatically diminishing market share. This presents a unique dilemma for firms depending

read more

copyright's Pill and Pharma : A Uncertain Opportunity?

The legacy of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in income, its patent expiration created a deluge of lower-priced alternatives , significantly eroding its position . While certain pharmaceutical companies may seek to capitalize on similar condit

read more